Sangamo Therapeutics To Present at the 37th Annual J.P. Morgan Healthcare Conference

RICHMOND, Calif., Jan. 4, 2019 /PRNewswire/ -- Sangamo Therapeutics, Inc. SGMO announced today that Sandy Macrae, CEO of Sangamo, will present a corporate overview at the 37^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9^th at 11:30 a.m. PT in San Francisco. Dr. Macrae's presentation will be followed by a separate Q&A session starting at 12:00 p.m. PT.

The presentation and Q&A session will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic medicines with the potential to transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit www.sangamo.com.

SOURCE Sangamo Therapeutics, Inc.